FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of Formula 1 as sphingosine-1-phosphate receptor agonists that can be effectively used to treat autoimmune diseases, to a process for preparing these compounds and to a pharmaceutical composition containing these compounds as an active ingredient.
Formula 1.
Q : CH2O or 
.
S: 
, 
,
, 
,
and 
.
EFFECT: compounds of the present invention are effective against autoimmune diseases and chronic inflammatory diseases, including relapsing-remitting multiple sclerosis, and can also be used to treat or prevent immunoregulatory disorders.
8 cl, 3 tbl, 161 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GPR40 RECEPTOR AGONIST, METHODS OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT | 2013 |
|
RU2650506C2 |
| DERIVATIVES (INDOLE-3-YL) HETEROCYCLIC COMPOUNDS AS AGONISTS OF CANNABINOID RECEPTORS CB1 | 2005 |
|
RU2376302C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| INDANONE DERIVATIVE, ITS PHARMACEUTICALLY ACCEPTABLE SALT OR ENANTIOMER, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AND APPLICABLE FOR PREVENTING OR TREATING VIRAL DISEASE | 2012 |
|
RU2574591C2 |
| INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
| BENZOINDAZOLONE COMPOUND AND INTERMEDIATE THEREOF | 2020 |
|
RU2782882C1 |
| TREATMENT METHOD | 2012 |
|
RU2621148C2 |
| BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | 2002 |
|
RU2304438C2 |
| N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
| BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
